We found recently that controlled progressive challenge with subthreshold levels of E. coli can confer progressively stronger resistance to future reinfection-induced sickness behavior to the host. We have termed this type of inflammation ''euflammation''. In this study, we further characterized the kinetic changes in the behavior, immunological, and neuroendocrine aspects of euflammation. Results show euflammatory animals only display transient and subtle sickness behaviors of anorexia, adipsia, and anhedonia upon a later infectious challenge which would have caused much more severe and longer lasting sickness behavior if given without prior euflammatory challenges. Similarly, infectious challengeinduced corticosterone secretion was greatly ameliorated in euflammatory animals. At the site of E. coli priming injections, which we termed euflammation induction locus (EIL), innate immune cells displayed a partial endotoxin tolerant phenotype with reduced expression of innate activation markers and muted inflammatory cytokine expression upon ex vivo LPS stimulation, whereas innate immune cells outside EIL displayed largely opposite characteristics. Bacterial clearance function, however, was enhanced both inside and outside EIL. Finally, sickness induction by an infectious challenge placed outside the EIL was also abrogated. These results suggest euflammation could be used as an efficient method to ''train'' the innate immune system to resist the consequences of future infectious/inflammatory challenges.
Introduction
Peripheral inflammation and the resultant release of cytokines have long been realized to be one of the main culprits in the pathogenesis of many CNS related disorders including, fatigue (Arnett and Clark, 2012), hyperalgesia (Sommer and Kress, 2004) , anorexia (Langhans, 2007) , and anhedonia (Salazar et al., 2012) . Collectively these have been termed ''sickness behavior '' (Kelley et al., 2003) . These centrally mediated sequelae are consistent features of systemic inflammation and are often associated with the presence of inflammagens or increased inflammatory cytokines in the blood. However, depending upon the level of the inflammatory challenge, sickness behavior may or may not manifest after localized peripheral inflammation. For example, well contained localized inflammation, such as those that occur during the healing of minor wounds, do not cause sickness behavior, but exhibit apparent local inflammatory histopathology including the infiltration of leukocytes and increased expression of inflammatory cytokines at the site of inflammation (Horan et al., 2005) . We have recently simulated the type of inflammation that is unaccompanied with overt concomitant sickness behaviors by local administration of subthreshold levels of LPS or live E. coli. Interestingly, the kinetic responses to consecutive daily administration of subthreshold levels of LPS and E. coli differed dramatically. We found prior exposure to subthreshold levels of LPS sensitized mice to display a greater sickness behavior response upon subsequent LPS challenges (Tarr et al., 2012) . However, following repeated E. coli administration, increased host resistance to the induction of sickness behavior by E. coli was evident if mice received prior challenges with subthreshold levels of E. coli (Chen et al., 2013) . We have thus termed a peripheral inflammation that does not cause overt sickness behavior, yet primes the immune system to provide more resistance to a subsequent inflammatory stimulation as ''euflammation.'' By using this definition we have restricted the training of innate immune activity within the boundary of ''absence of overt sickness behavior'', thereby preventing changes in the innate immunity from reaching hyper-inflammation.
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